222 related articles for article (PubMed ID: 10374713)
1. Relationship between myocardial cation content and injury in reperfused rat hearts treated with cation channel blockers.
Tanonaka K; Kajiwara H; Kameda H; Takasaki A; Takeo S
Eur J Pharmacol; 1999 May; 372(1):37-48. PubMed ID: 10374713
[TBL] [Abstract][Full Text] [Related]
2. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
3. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
[TBL] [Abstract][Full Text] [Related]
4. [Effects of KB-R7943, a novel Na+/Ca2+ exchange inhibitor, on myocardial ischemia/reperfusion injury].
Nakamura A; Harada K; Sugimoto H; Nakajima F; Nishimura N
Nihon Yakurigaku Zasshi; 1998 Feb; 111(2):105-15. PubMed ID: 9558649
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
6. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts.
Takeo S; Tanonaka K; Hayashi M; Yamamoto K; Liu JX; Kamiyama T; Yamaguchi N; Miura A; Natsukawa T
J Pharmacol Exp Ther; 1995 Jun; 273(3):1403-9. PubMed ID: 7791114
[TBL] [Abstract][Full Text] [Related]
7. Effects of aprindine on ischemia/reperfusion-induced cardiac contractile dysfunction of perfused rat heart.
Kamiyama T; Tanonaka K; Hayashi J; Takeo S
Jpn J Pharmacol; 1996 Mar; 70(3):227-34. PubMed ID: 8935716
[TBL] [Abstract][Full Text] [Related]
8. Propafenone and disopyramide enhance post-ischemic contractile and metabolic recovery of perfused hearts.
Liu JX; Tanonaka K; Yamamoto K; Takeo S
Eur J Pharmacol; 1993 Dec; 250(3):361-9. PubMed ID: 8112396
[TBL] [Abstract][Full Text] [Related]
9. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
11. Effects of TA-3090, a new calcium channel blocker, on myocardial substrate utilization in ischemic and nonischemic isolated working fatty acid-perfused rat hearts.
Davies NJ; McVeigh JJ; Lopaschuk GD
Circ Res; 1991 Mar; 68(3):807-17. PubMed ID: 1742868
[TBL] [Abstract][Full Text] [Related]
12. Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart.
Tanonaka K; Taguchi T; Koshimizu M; Ando T; Morinaka T; Yogo T; Konishi F; Takeo S
J Pharmacol Exp Ther; 1999 Nov; 291(2):710-6. PubMed ID: 10525091
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts.
Akita T; Abe T; Kato S; Kodama I; Toyama J
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005
[TBL] [Abstract][Full Text] [Related]
14. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
Grover GJ; Sleph PG; Dzwonczyk S; Malone HJ; Behling RW
J Cardiovasc Pharmacol; 1997 Jan; 29(1):28-38. PubMed ID: 9007667
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
[TBL] [Abstract][Full Text] [Related]
16. Effects of N-(2-mercaptopropionyl)-glycine on mitochondrial function in ischemic-reperfused heart.
Tanonaka K; Iwai T; Motegi K; Takeo S
Cardiovasc Res; 2003 Feb; 57(2):416-25. PubMed ID: 12566114
[TBL] [Abstract][Full Text] [Related]
17. Improvement of ischemia/reperfusion-induced contractile dysfunction of perfused hearts by class Ic antiarrhythmic agents.
Liu JX; Tanonaka K; Ohtsuka Y; Sakai Y; Takeo S
J Pharmacol Exp Ther; 1993 Sep; 266(3):1247-54. PubMed ID: 8371134
[TBL] [Abstract][Full Text] [Related]
18. Preservation of mitochondrial function may contribute to cardioprotective effects of Na+/Ca2+ exchanger inhibitors in ischaemic/reperfused rat hearts.
Motegi K; Tanonaka K; Takenaga Y; Takagi N; Takeo S
Br J Pharmacol; 2007 Aug; 151(7):963-78. PubMed ID: 17549042
[TBL] [Abstract][Full Text] [Related]
19. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
20. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
Becker BF; Möbert J
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
